
### [NCIT:C4180](http://purl.obolibrary.org/obo/NCIT_C4180)
**Label:** Papillary Serous Cystadenoma

**Subclasses:** [NCIT:C7278](http://purl.obolibrary.org/obo/NCIT_C7278) (Ovarian Papillary Cystadenoma), [NCIT:C4183](http://purl.obolibrary.org/obo/NCIT_C4183) (Borderline Papillary Serous Cystadenoma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37115](http://purl.obolibrary.org/obo/NCIT_C37115) (Serous Adenocarcinoma Cell))) 53.12%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39092](http://purl.obolibrary.org/obo/NCIT_C39092) (Growth Hormone Signaling Pathway))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39091](http://purl.obolibrary.org/obo/NCIT_C39091) (Corticosteroid Cardioprotection Pathway))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39088](http://purl.obolibrary.org/obo/NCIT_C39088) (G2/M Checkpoint Pathway))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39079](http://purl.obolibrary.org/obo/NCIT_C39079) (Fc Epsilon Receptor I Signaling Pathway BioCarta))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39072](http://purl.obolibrary.org/obo/NCIT_C39072) (Erk1/Erk2 MAPK Signaling Pathway))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C39071](http://purl.obolibrary.org/obo/NCIT_C39071) (Neuronal Survival Pathway))) 38.48%


